Nanobodies as novel agents for disease diagnosis and therapy

Christina G Siontorou Department of Industrial Management and Technology, University of Piraeus, Piraeus, Greece Abstract: The discovery of naturally occurring, heavy-chain only antibodies in Camelidae, and their further development into small recombinant nanobodies, presents attractive alternatives...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Siontorou CG
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2013
Materias:
Acceso en línea:https://doaj.org/article/1749be6960c9450bbf09a95555703e60
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1749be6960c9450bbf09a95555703e60
record_format dspace
spelling oai:doaj.org-article:1749be6960c9450bbf09a95555703e602021-12-02T11:07:29ZNanobodies as novel agents for disease diagnosis and therapy1176-91141178-2013https://doaj.org/article/1749be6960c9450bbf09a95555703e602013-11-01T00:00:00Zhttp://www.dovepress.com/nanobodies-as-novel-agents-for-disease-diagnosis-and-therapy-a14870https://doaj.org/toc/1176-9114https://doaj.org/toc/1178-2013Christina G Siontorou Department of Industrial Management and Technology, University of Piraeus, Piraeus, Greece Abstract: The discovery of naturally occurring, heavy-chain only antibodies in Camelidae, and their further development into small recombinant nanobodies, presents attractive alternatives in drug delivery and imaging. Easily expressed in microorganisms and amenable to engineering, nanobody derivatives are soluble, stable, versatile, and have unique refolding capacities, reduced aggregation tendencies, and high-target binding capabilities. This review outlines the current state of the art in nanobodies, focusing on their structural features and properties, production, technology, and the potential for modulating immune functions and for targeting tumors, toxins, and microbes. Keywords: heavy chain antibodies, nanobodies, antibody expression, molecular display, formattingSiontorou CGDove Medical PressarticleMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol 2013, Iss Issue 1, Pp 4215-4227 (2013)
institution DOAJ
collection DOAJ
language EN
topic Medicine (General)
R5-920
spellingShingle Medicine (General)
R5-920
Siontorou CG
Nanobodies as novel agents for disease diagnosis and therapy
description Christina G Siontorou Department of Industrial Management and Technology, University of Piraeus, Piraeus, Greece Abstract: The discovery of naturally occurring, heavy-chain only antibodies in Camelidae, and their further development into small recombinant nanobodies, presents attractive alternatives in drug delivery and imaging. Easily expressed in microorganisms and amenable to engineering, nanobody derivatives are soluble, stable, versatile, and have unique refolding capacities, reduced aggregation tendencies, and high-target binding capabilities. This review outlines the current state of the art in nanobodies, focusing on their structural features and properties, production, technology, and the potential for modulating immune functions and for targeting tumors, toxins, and microbes. Keywords: heavy chain antibodies, nanobodies, antibody expression, molecular display, formatting
format article
author Siontorou CG
author_facet Siontorou CG
author_sort Siontorou CG
title Nanobodies as novel agents for disease diagnosis and therapy
title_short Nanobodies as novel agents for disease diagnosis and therapy
title_full Nanobodies as novel agents for disease diagnosis and therapy
title_fullStr Nanobodies as novel agents for disease diagnosis and therapy
title_full_unstemmed Nanobodies as novel agents for disease diagnosis and therapy
title_sort nanobodies as novel agents for disease diagnosis and therapy
publisher Dove Medical Press
publishDate 2013
url https://doaj.org/article/1749be6960c9450bbf09a95555703e60
work_keys_str_mv AT siontoroucg nanobodiesasnovelagentsfordiseasediagnosisandtherapy
_version_ 1718396216190959616